Evidence map›Paper›PMID 24336192›Full record

ArticleCarcinogenesis2014

Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures.

Charlotte Sagne, Virginie Marcel, Maria Bota, Ghyslaine Martel-Planche, Amanda Nobrega, Edenir Inêz Palmero, Laury Perriaud, Mathieu Boniol, Stephan Vagner, David G Cox and 7 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02289326 (Biomarker Monitoring for a Young Individual Carrying a TP53 Gene Mutation in a Familial High-Cancer Predisposition Setting), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02289326 completednot on this map

Biomarker Monitoring for a Young Individual Carrying a TP53 Gene Mutation in a Familial High-Cancer Predisposition Setting

TypeobservationalSponsorScripps HealthRan2014 to 2016Enrolled6ConditionsLi-Fraumeni Syndrome, Hereditary Cancer Syndromes, TP53 Gene Germline Mutation Carrier
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.International journal of clinical oncology · 2021
    Article
  7. Review: Ewing Sarcoma Predisposition.Pathology oncology research : POR · 2020
    Review
  8. Li-Fraumeni syndrome heterogeneity.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Review
  9. Review
  10. Germline mutation ofScience advances · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Inherited p53 Mutation in the Brazilian Population.Cold Spring Harbor perspectives in medicine · 2016
    Review
  18. Article
  19. Article
  20. Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 4 countries.

Charlotte SagneINSERM U612, Bât 110-112, Centre Universitaire, Orsay 91405, France.
Virginie Marcel
Maria Bota
Ghyslaine Martel-Planche
Amanda Nobrega
Edenir Inêz Palmero
Laury Perriaud
Mathieu Boniol
Stephan Vagner
David G Cox
Chang S Chan
Jean-Louis Mergny
Magali Olivier
Patricia Ashton-Prolla
Janet Hall
Pierre Hainaut
Maria Isabel Achatz
Inserm · FRAC Camargo Hospital · BRCentre international de recherche sur le cancer · FRInternational Prevention Research Institute · FRUniversité Claude Bernard Lyon 1 · FRCenter for Systems Biology · USCentre National de la Recherche Scientifique · FRHospital de Câncer de Barretos · BRUniversidade Federal do Rio Grande do Sul · BRUniversité de Bordeaux · FR

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
NCI NIH HHS P30 CA072720
6 · The paper itself

Abstract

Germline TP53 mutations predispose to multiple cancers defining Li-Fraumeni/Li-Fraumeni-like syndrome (LFS/LFL), a disease with large individual disparities in cancer profiles and age of onset. G-quadruplexes (G4s) are secondary structural motifs occurring in guanine tracks, with regulatory effects on DNA and RNA. We analyzed 85 polymorphisms within or near five predicted G4s in TP53 in search of modifiers of penetrance of LFS/LFL in Brazilian cancer families with (n = 35) or without (n = 110) TP53 mutations. Statistical analyses stratified on family structure showed that cancer tended to occur ~15 years later in mutation carriers who also carried the variant alleles of two polymorphisms within predicted G4-forming regions, rs17878362 (TP53 PIN3, 16 bp duplication in intron 3; P = 0.082) and rs17880560 (6 bp duplication in 3' flanking region; P = 0.067). Haplotype analysis showed that this inverse association was driven by the polymorphic status of the remaining wild-type (WT) haplotype in mutation carriers: in carriers with a WT haplotype containing at least one variant allele of rs17878362 or rs17880560, cancer occurred ~15 years later than in carriers with other WT haplotypes (P = 0.019). No effect on age of cancer onset was observed in subjects without a TP53 mutation. The G4 in intron 3 has been shown to regulate alternative p53 messenger RNA splicing, whereas the biological roles of predicted G4s in the 3' flanking region remain to be elucidated. In conclusion, this study demonstrates that G4 polymorphisms in haplotypes of the WT TP53 allele have an impact on LFS/LFL penetrance in germline TP53 mutation carriers.

Indexed as

Age of OnsetGenes, p53Genetic Carrier ScreeningG-QuadruplexesPolymorphism, GeneticBase SequenceDNAHumansMolecular Sequence DataNeoplasmsDNA

Identifiers

PMID24336192
PMCPMC3977145
OpenAlexW2164008445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.